NMPA Approval

Ganciclovir for Injection

Approval Number

H20130374

Registration Date

February 17, 2020

Previous Approval Numbers

H20130374

Drug Information

Generic Name

注射用更昔洛韦

Trade Name

赛美维

Brand Name

赛美维

Dosage Form

注射剂

Strength

0.5克

Drug Type

化学药品

Registration Date

February 17, 2020

Expiry Date

January 21, 2024

Company Address

Ziegelhof 24, 17489 Greifswald, Germany

Company Address

Via Appia Km. 65,561 04013 Latina Scalo LT Italy

Empowering clinical research with data-driven insights and AI-powered tools.

注射用更昔洛韦 - NMPA 批准文号 | MedPath